Stefano Luminari

28PUBLICATIONS
138CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 31, 2026
Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study.

|Jun 08, 2026
Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

|Apr 20, 2026
Dynamics of complete responses (CRs) in patients with relapsed or refractory follicular lymphoma (R/R FL) treated with odronextamab in the ELM-2 study.

|Mar 09, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study.

Nicolò Danesin, Francesco Autore, Anna Maria Frustaci

|Jan 09, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.

Hervé Ghesquières, Youenn Drouet, Susan L Slager

|Oct 15, 2025
The emerging role of tafasitamab in follicular lymphoma.

Tanja Lazic, Emiliano Barbieri, Stefano Luminari

Pageof 5

Frequent Collaborators

9 joint publications

Luca Arcaini

6 joint publications

Michele Merli

5 joint publications

Simone Ferrero

4 joint publications

Vittorio Ruggero Zilioli